Related Experiment Video
Updated: Oct 19, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Mechanism and adverse effects of COVID-19 drugs: a basic review
Nadia Mohammad Zadeh1, Nazli Sadat Mashinchi Asl2, Khatereh Forouharnejad3
1School of Medicine, Islamic Azad University Tehran Faculty of Medicine Tehran, Iran.
Abstract:
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 (COVID-19) is chronic, inflammatory. Although the exact mechanisms of COVID-19 have not been yet discovered some drugs are found helpful for its treatment. These drugs which are divided into some lines therapies, have demonstrated to be helpful for COVID-19 patients based on immune basic and its antiviral properties of the disease. Previous studies have been indicated that deterioration of COVID-19 condition is associated with a weaker immune system. Most of these therapies impact on the immune system and immune cells. Beside many beneficial effects of these drugs, some adverse effects (AE) have been reported in many experiments and clinical trials among patients suffering from COVID-19. In this review, we conclude some AEs of vitamin-D, zinc, remdesivir, hydroxychloroquine or chloroquine, azithromycin, dexamethasone, amantadine, aspirin reported in different papers and we continue the rest of the drugs in second part of our review article.
Insights
This review summarizes adverse effects of various COVID-19 treatments, including vitamin D, zinc, and remdesivir. Understanding these side effects is crucial for managing coronavirus disease 2019 (COVID-19) patient care.
Area of Science:
- Infectious Diseases
- Pharmacology
- Immunology
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is a chronic inflammatory condition.
- Deterioration in COVID-19 patients is often linked to a compromised immune system.
- Current treatments for COVID-19 leverage immune-based and antiviral properties.
Purpose of the Study:
- To review and summarize reported adverse effects of various drugs used in COVID-19 treatment.
- To provide a comprehensive overview of potential side effects associated with common COVID-19 therapies.
- To inform clinicians and researchers about the safety profiles of COVID-19 medications.
Main Methods:
- Literature review of scientific papers and clinical trials.
- Identification and compilation of adverse events associated with specific COVID-19 drugs.
- Categorization of adverse effects based on drug and therapeutic line.
Main Results:
- Adverse effects were documented for vitamin D, zinc, remdesivir, hydroxychloroquine/chloroquine, azithromycin, dexamethasone, amantadine, and aspirin.
- These side effects were observed in various experimental and clinical settings.
- The review highlights the importance of monitoring for adverse events during COVID-19 treatment.
Conclusions:
- Various medications used for COVID-19 treatment present a range of adverse effects.
- Careful consideration of drug safety profiles is essential for effective patient management.
- Further research is needed to fully understand and mitigate the risks associated with COVID-19 therapies.
Related Concept Videos
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Pharmacokinetics: Drug–Drug Interactions
Effects of Chemicals: Overview
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...

